Innovating Works
MyoTreat: Myopia - from genes and environment to cellular responses and treatment TRB Chemedica International SA participó en un HORIZON EUROPE: HORIZON-MSCA-2022-DN-01 "In modern industrial societies, myopia has become an important ocular health problem of young people, due to its increased incidence and as...
2023-07-12 - 2027-11-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.